Lion’s Mane (Hericium erinaceus) has attracted growing scientific attention as a candidate for supporting cognitive health in aging populations. Unlike many nootropic claims that rest on anecdote, a small but meaningful body of peer-reviewed research has examined this mushroom’s compounds in the context of age-related cognitive decline. This article reviews what that research currently shows, where the evidence remains limited, and what questions remain open.
What Makes Lion’s Mane Relevant to Aging and Cognition?
Two classes of compounds unique to Hericium erinaceus have drawn particular interest from researchers: hericenones, found primarily in the fruiting body, and erinacines, concentrated in the mycelium. Both compound classes have been studied for their capacity to stimulate the synthesis of nerve growth factor (NGF), a protein that plays a central role in the maintenance and survival of neurons.
NGF production naturally declines with age, and this reduction has been associated with the kind of neuronal deterioration seen in mild cognitive impairment and neurodegenerative conditions. The hypothesis underlying much of the Lion’s Mane research is that compounds which support NGF synthesis may help slow or partially offset this age-related decline. A 2016 study published in the Journal of Biomedical Science found that erinacine A-enriched mycelium may reduce Alzheimer’s-related pathological markers in a transgenic mouse model, suggesting a mechanism involving NGF upregulation and reduced amyloid beta accumulation.[1]
The Landmark Human Clinical Trial
The most widely cited human evidence comes from a double-blind, placebo-controlled clinical trial published in Phytotherapy Research in 2009. The study enrolled Japanese men and women between 50 and 80 years of age who had been diagnosed with mild cognitive impairment. Participants in the treatment group were administered Hericium erinaceus dry powder tablets over 16 weeks. Cognitive function was assessed at intervals using the Revised Hasegawa Dementia Scale (HDS-R).
The researchers found that participants receiving the mushroom extract showed significantly higher cognitive function scores at weeks 8, 12, and 16 compared to the placebo group. Scores increased in a dose-duration-dependent pattern. Importantly, when supplementation ended, scores declined over the subsequent four-week observation period, which suggests the effect may be dependent on continued intake. No adverse effects were detected in laboratory testing throughout the trial.[2]
While this trial was small (30 subjects), its randomized, placebo-controlled design and the consistency of results across multiple time points make it a frequently referenced benchmark in the functional mushroom literature.
What Systematic Reviews Currently Show
A 2025 systematic review published in Frontiers in Nutrition analyzed five randomized controlled trials, three pilot clinical trials, and multiple laboratory studies examining Hericium erinaceus as a supplement. Across the RCTs and pilot trials, Mini-Mental State Examination (MMSE) scores in intervention groups showed a combined weighted mean increase of 1.17 compared to controls. The review also noted that HE supplementation was associated with increases in BDNF (brain-derived neurotrophic factor) and pro-BDNF, improvements in hippocampal neurogenesis markers in animal models, and a reduction in neuroinflammatory indicators. The authors described the safety profile as generally favorable across included studies.[3]
It is worth noting that the effect size on cognitive measures, while statistically significant in several trials, remains modest. Researchers consistently emphasize the need for larger, longer-duration trials before strong clinical recommendations can be made.
The Gut-Brain Axis Connection
Emerging research has examined Lion’s Mane through the lens of the gut-brain axis, a bidirectional communication pathway between the gastrointestinal tract and central nervous system. A 2023 study in Biology found that Hericium erinaceus extract administered to elderly mice improved markers on the gut-neuroinflammaging-cognitive axis. The researchers observed reductions in neuroinflammatory markers alongside improvements in gut microbiome diversity, suggesting a potential indirect pathway by which the mushroom may influence cognitive outcomes in aging subjects.[4]
This line of investigation is still early-stage, but it points toward a more complex mechanism than NGF stimulation alone. The interplay between intestinal flora, inflammatory signaling, and brain function represents one of the more active areas of current research in functional mushroom science.
Key Limitations of the Current Evidence
Several important caveats apply to interpreting the existing literature on Lion’s Mane and cognitive aging:
Sample Sizes Remain Small
The majority of human clinical trials to date have enrolled fewer than 100 participants. Small samples limit the statistical power needed to detect modest effects reliably and reduce the generalizability of findings.
Study Populations Vary
Some trials have enrolled individuals with diagnosed mild cognitive impairment, while others have included cognitively healthy adults. These are different populations with different baselines, and results may not translate across them.
Standardization Challenges
The bioactive compound profile of Hericium erinaceus products varies depending on whether the source is fruiting body or mycelium, how the extract is prepared, and the concentration of hericenones or erinacines. Studies use different preparations, making direct comparisons difficult.
Reversibility of Effects
As observed in the 2009 Mori trial, cognitive improvements appeared to diminish after supplementation was discontinued. This raises questions about the nature and durability of the benefit and the practical implications for long-term use.
How This Compares to Other Mushrooms Used for Brain Health
Among the functional mushrooms studied for neurological endpoints, Lion’s Mane stands out for having the most direct mechanistic rationale tied to NGF and BDNF modulation. Other species such as Reishi (Ganoderma lucidum) and Cordyceps have been studied for indirect neuroprotective effects through anti-inflammatory and antioxidant pathways, but lack the same volume of human clinical data specifically targeting cognitive decline. For a broader comparison of species used for cognitive support, see our overview of the best mushrooms for brain health.
Considerations for Adults Interested in Lion’s Mane
Research suggests that Hericium erinaceus is generally well tolerated in the doses used across clinical studies, with no significant adverse events reported in published trials. However, individuals with mushroom allergies should exercise caution, and anyone taking medications that affect the central nervous system or blood clotting should consult a healthcare provider before adding Lion’s Mane to their regimen.
The existing evidence does not support specific dosing claims outside the context of individual named studies. Persons considering supplementation should evaluate product quality markers such as beta-glucan content, extraction method, and whether independent third-party testing has been conducted.
Conclusion
The research on Lion’s Mane mushroom and cognitive decline in aging is among the more developed in the functional mushroom field, anchored by a landmark human RCT, a 2025 systematic review, and mechanistic animal studies examining NGF, BDNF, and gut-brain axis pathways. The evidence is encouraging but preliminary. Research suggests Lion’s Mane may support cognitive function in adults with mild cognitive impairment, though larger and longer trials are needed before definitive conclusions can be drawn. For individuals and clinicians evaluating options, the current data supports cautious interest rather than confident prescription.
References
- Tsai-Teng T, et al. Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice. J Biomed Sci. 2016;23(1):49. PMID: 27350344
- Mori K, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367-72. PMID: 18844328
- Menon A, et al. Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. Front Nutr. 2025;12:1641246. PMID: 40959699
- Priori EC, et al. Hericium erinaceus Extract Exerts Beneficial Effects on Gut-Neuroinflammaging-Cognitive Axis in Elderly Mice. Biology (Basel). 2023;13(1):18. PMID: 38248449
Disclaimer: This article is for informational purposes only and does not constitute medical advice. The statements in this article have not been evaluated by the Food and Drug Administration. Functional mushroom supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before making changes to your supplement regimen.
